Heart Transplantation (Grafting, Heart)

Subscribe to Selected New Research on Heart Transplantation

5054 relevant articles (246 outcomes, 361 trials/studies) found for this Therapy

Description: The transference of a heart from one human or animal to another.

Also Known As:

Grafting, Heart; Cardiac Transplantations; Graftings, Heart; Heart Grafting; Heart Graftings; Heart Transplantations; Transplantations, Cardiac; Transplantations, Heart; Cardiac Transplantation; Transplantation, Cardiac; Transplantation, Heart

Relationship Network

Therapy Context: Research Results

Operative Surgical Procedures: 4

Transplantation: 36585

Organ Transplantation: 2370

Heart Transplantation: 5054

Heart-Lung Transplantation: 449

Thoracic Surgical Procedures: 43

Cardiac Surgical Procedures: 202

Heart Transplantation: 5054

Heart-Lung Transplantation: 449

Cardiovascular Surgical Procedures: 18

Cardiac Surgical Procedures: 202

Heart Transplantation: 5054

Heart-Lung Transplantation: 449

Experts

1.	Potena, Luciano: 7 articles (03/2008 - 08/2002)
2.	Hetzer, Roland: 7 articles (08/2007 - 11/2002)
3.	Canter, Charles E: 7 articles (05/2007 - 04/2002)
4.	Young, James B: 7 articles (05/2005 - 02/2003)
5.	Wang, Shoei-Shen: 6 articles (08/2008 - 01/2002)
6.	Banner, N R: 6 articles (05/2008 - 04/2000)
7.	Branzi, Angelo: 6 articles (03/2008 - 08/2002)
8.	Grigioni, Francesco: 6 articles (03/2008 - 08/2002)
9.	Tenderich, Gero: 6 articles (06/2007 - 10/2002)
10.	Blume, Elizabeth D: 6 articles (02/2007 - 06/2003)

Related Diseases

1.	Heart Failure 01/01/2008 - "Despite much progress in development of many new drugs and innovations in palliative surgical strategy, nontransplant cardiac surgical procedures and the use of mechanical assist devices, pediatric heart transplantation remains the best treatment option for patients with end-stage heart failure" 03/16/2007 - "Cardiac transplantation is the most effective treatment for advanced heart failure" 01/01/2007 - "At present the most effective cure for end-stage congestive heart failure is cardiac transplantation" 02/01/2005 - "LVAD as bridge to heart transplantation is safe and highly beneficial for terminal heart failure patients with severe PH." 12/01/2003 - "Heart transplantation remains the best treatment option for end-stage heart failure" Get all the results and reference details, order at left...
2.	Heart Diseases (Heart Disease) 11/01/2007 - "BACKGROUND: Despite being accepted as the best treatment for end-stage heart diseases, the long-term benefit of heart transplantation in children remains a matter of controversial debate" 03/01/2000 - "Cardiac transplantation provides the best option for neonates with congenital heart disease that is not amenable to surgical repair or palliation" 02/01/1999 - "With a survival rate of 70% at 3 years, cardiac transplantation is the best treatment for end-stage heart disease" 10/01/1993 - "Our data demonstrate that after heart transplantation prognosis of end-stage cardiac disease is highly improved either for life expectancy and for quality of life" 01/01/1991 - "Orthotopic heart transplantation continues to be a highly successful therapy for end-stage cardiac disease" Get all the results and reference details, order at left...
3.	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 02/01/1996 - "These results indicate that structural microangiopathy and minimal vascular resistance in skin are improved slowly and gradually within the first year after orthotopic cardiac transplantation in patients with idiopathic dilated cardiomyopathy, however, the remodeling of histopathology is not accompanied by complete normalization." 03/01/1994 - "A minority of patients with dilated cardiomyopathy and symptoms for < or = 6 months will have marked improvement in left ventricular function, after which prognosis is excellent despite previous referral for heart transplantation" 04/01/2003 - "Advances in medical therapy for dilated cardiomyopathy and cardiac transplantation have significantly improved the quality of life and survival for patients." 02/01/1998 - "The utility of immunosuppressive therapy remains ambiguous; however, other advances in medical therapy for dilated cardiomyopathy and cardiac transplantation have significantly improved quality of life and survival for patients" 07/01/1995 - "Prognosis of congestive cardiomyopathy, although generally poor, can be greatly improved by a rational pharmacological therapy as well as new interventions (implantable defibrillator, cardiac transplantation) whose correct indications rely on technological advances and a better knowledge of the natural history of the disease." Get all the results and reference details, order at left...
4.	Cardiomyopathies (Cardiomyopathy) 02/15/2006 - "Infant heart transplantation is highly successful therapy for severe congenital heart malformations and cardiomyopathies" 06/25/2002 - "Heart transplantation is the most effective treatment for the otherwise lethal cardiomyopathy" 07/01/1990 - "Since the early 1980s, a rapid increase in successful pediatric heart transplantation has improved the chance of survival for many children suffering from otherwise fatal cardiomyopathies or congenital cardiac defects" 08/01/1992 - "The great clinical improvement and positive changes in left ventricular parameters suggest that cardiomyoplasty is useful in the treatment of some cases of dilated or ischemic cardiomyopathy as an alternative to heart transplantation" 03/01/1994 - "Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation." Get all the results and reference details, order at left...
5.	Pulmonary Hypertension (Ayerza Syndrome) 02/01/2004 - "Right ventricle-sparing heart transplantation effective against iatrogenic pulmonary hypertension." 05/01/2004 - "We describe a patient whose previously fixed pulmonary hypertension improved to the point that she was once again considered eligible for cardiac transplantation." 01/01/1996 - "This agent also holds promise for evaluating patients with pulmonary hypertension prior to heart transplantation" 05/01/2007 - "CONCLUSIONS: This study supports that LVAD support and continuous nonpulsatile mechanical unloading of the left ventricle can reverse medically unresponsive pulmonary hypertension and render patients eligible for orthotopic heart transplantation." 01/01/2006 - "AIM OF THE STUDY: evaluation of pulmonary hypertension in candidates for heart transplantation" Get all the results and reference details, order at left...
617 Diseases and 5054 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Cyclosporine (Ciclosporin)
2.	Immunosuppressive Agents (Immunosuppressants)
3.	Oxygen
4.	Enoximone
5.	Pravastatin (Pravachol)
6.	Alprostadil (Muse)
7.	Vasodilator Agents (Vasodilators)
8.	Lovastatin (Mevacor)
9.	Endothelin Receptors (Endothelin Receptor)
10.	Iloprost (Ventavis)
466 Drugs and Important Bio-Agents and 881 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Transplants (Transplant)
2.	Transplantation (Transplant Recipients)
3.	Homologous Transplantation (Allograft)
4.	Cardiomyoplasty
5.	Drug Therapy (Chemotherapy)
109 Therapies and Procedures and 1087 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>